Greenwich LifeSciences GLSI
NASDAQ GLSI
$17.02 -0.33 (-1.87%)
As of: Oct 2, 2026 · 1:14 PM EDT

Greenwich LifeSciences (GLSI) Accumulated Expenses (2020 - 2024)

Updated

Greenwich LifeSciences (GLSI) recorded Accumulated Expenses of $220,845 in Q2 2024, unchanged from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Accumulated Expenses (2020 - 2024) Analysis & Trends

Starting with Q3 2020, Greenwich LifeSciences' Accumulated Expenses history includes 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Greenwich LifeSciences 264.72 Mn 264.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 220,845.00
Mar 31, 2024 220,845.00
Dec 31, 2023 220,845.00
Sep 30, 2020 42,580.00
API Access

Greenwich LifeSciences Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=GLSI&period=max&api_key=YOUR_API_KEY